See more : Fujian Cosunter Pharmaceutical Co., Ltd. (300436.SZ) Income Statement Analysis – Financial Results
Complete financial analysis of CareCloud, Inc. (CCLD) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of CareCloud, Inc., a leading company in the Medical – Healthcare Information Services industry within the Healthcare sector.
- Global Payments Inc. (0IW7.L) Income Statement Analysis – Financial Results
- George Weston Limited (WN-PA.TO) Income Statement Analysis – Financial Results
- ES Bancshares, Inc. (ESBS) Income Statement Analysis – Financial Results
- Rua Gold Inc. (NZAUF) Income Statement Analysis – Financial Results
- AppTech Payments Corp. (APCXW) Income Statement Analysis – Financial Results
CareCloud, Inc. (CCLD)
Industry: Medical - Healthcare Information Services
Sector: Healthcare
Website: https://www.carecloud.com
About CareCloud, Inc.
CareCloud, Inc., a healthcare information technology (IT) company, provides a suite of cloud-based solutions and related business services to healthcare providers and hospitals primarily in the United States. It operates in two segments, Healthcare IT and Medical Practice Management. The company's Software-as-a-Service platform includes revenue cycle management, practice management, electronic health record, business intelligence, telehealth, and patient experience management solutions, as well as complementary software tools and business services for medical groups and health systems. It serves physicians, nurses, nurse practitioners, physician assistants, and other clinicians that render bills for their services. The company was formerly known as MTBC, Inc. and changed its name to CareCloud, Inc. in March 2021. CareCloud, Inc. was founded in 1999 and is headquartered in Somerset, New Jersey.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 117.06M | 138.83M | 139.60M | 105.12M | 64.44M | 50.55M | 31.81M | 24.49M | 23.08M | 18.30M | 10.47M | 10.02M | 10.09M |
| Cost of Revenue | 70.82M | 84.43M | 86.92M | 64.82M | 41.19M | 31.25M | 17.68M | 13.42M | 11.63M | 10.64M | 4.27M | 4.26M | 4.51M |
| Gross Profit | 46.24M | 54.39M | 52.68M | 40.30M | 23.25M | 19.29M | 14.13M | 11.08M | 11.45M | 7.67M | 6.20M | 5.76M | 5.58M |
| Gross Profit Ratio | 39.50% | 39.18% | 37.74% | 38.34% | 36.08% | 38.17% | 44.42% | 45.22% | 49.61% | 41.89% | 59.20% | 57.50% | 55.33% |
| Research & Development | 4.74M | 4.40M | 4.41M | 9.31M | 870.78K | 1.03M | 1.08M | 902.19K | 659.18K | 531.68K | 386.11K | 396.43K | 410.13K |
| General & Administrative | 21.46M | 23.82M | 24.27M | 22.81M | 17.91M | 16.26M | 11.74M | 12.46M | 11.97M | 9.94M | 4.74M | 4.40M | 3.83M |
| Selling & Marketing | 9.65M | 9.79M | 8.79M | 6.58M | 1.52M | 1.61M | 1.11M | 1.22M | 467.45K | 253.28K | 248.98K | 266.41K | 197.59K |
| SG&A | 31.11M | 33.61M | 33.06M | 29.39M | 19.43M | 17.88M | 12.84M | 13.68M | 12.44M | 10.20M | 4.99M | 4.66M | 4.03M |
| Other Expenses | 57.51M | 11.73M | 12.20M | 9.91M | 3.01M | 59.53K | 83.57K | -53.28K | 26.95K | -134.72K | 30.23K | 15.12K | 46.53K |
| Operating Expenses | 93.36M | 49.73M | 49.66M | 48.61M | 23.31M | 21.76M | 18.23M | 19.69M | 17.69M | 13.52M | 6.33M | 5.74M | 4.99M |
| Cost & Expenses | 164.17M | 134.17M | 136.58M | 113.43M | 64.50M | 53.01M | 35.91M | 33.11M | 29.32M | 24.16M | 10.60M | 10.00M | 9.49M |
| Interest Income | 154.00K | 41.00K | 15.00K | 42.00K | 262.00K | 100.79K | 16.94K | 36.41K | 26.80K | 26.61K | 23.93K | 23.38K | 47.70K |
| Interest Expense | 1.19M | 405.00K | 455.00K | 488.00K | 382.67K | 351.17K | 1.32M | 682.08K | 288.41K | 183.47K | 160.07K | 97.03K | 63.61K |
| Depreciation & Amortization | 16.55M | 15.01M | 15.77M | 12.79M | 4.89M | 2.85M | 4.30M | 5.11M | 4.60M | 2.79M | 948.53K | 678.73K | 545.57K |
| EBITDA | -31.29M | 21.03M | 19.22M | 4.57M | 3.13M | 909.13K | 126.81K | -2.81M | 337.42K | -1.36M | 1.10M | 892.75K | 1.32M |
| EBITDA Ratio | -26.73% | 14.17% | 11.18% | 1.78% | 4.11% | 1.20% | 0.96% | -14.39% | -6.90% | -17.32% | 8.36% | 7.38% | 12.26% |
| Operating Income | -47.12M | 4.06M | 3.53M | -8.26M | -421.10K | -2.54M | -4.52M | -7.90M | -4.46M | -4.04M | -127.52K | 22.02K | 597.06K |
| Operating Income Ratio | -40.25% | 2.93% | 2.53% | -7.86% | -0.65% | -5.02% | -14.22% | -32.26% | -19.32% | -22.08% | -1.22% | 0.22% | 5.92% |
| Total Other Income/Expenses | -1.92M | -1.00M | -536.00K | -439.00K | -746.02K | 243.95K | -975.19K | -698.95K | -91.33K | -291.58K | 94.01K | -31.30K | 116.67K |
| Income Before Tax | -49.04M | 5.61M | 2.99M | -8.71M | -679.02K | -2.30M | -5.50M | -8.60M | -4.55M | -4.33M | -33.51K | 116.99K | 713.73K |
| Income Before Tax Ratio | -41.89% | 4.04% | 2.14% | -8.29% | -1.05% | -4.54% | -17.28% | -35.11% | -19.71% | -23.67% | -0.32% | 1.17% | 7.07% |
| Income Tax Expense | -364.00K | 177.00K | 157.00K | 103.00K | 192.78K | -157.39K | 67.81K | 196.80K | 137.79K | 176.53K | 144.49K | -4.00 | 243.84K |
| Net Income | -48.67M | 5.43M | 2.84M | -8.81M | -871.80K | -2.14M | -5.57M | -8.80M | -4.69M | -4.51M | -178.00K | 117.00K | 469.90K |
| Net Income Ratio | -41.58% | 3.91% | 2.03% | -8.38% | -1.35% | -4.23% | -17.49% | -35.91% | -20.31% | -24.64% | -1.70% | 1.17% | 4.66% |
| EPS | -4.11 | 0.36 | 0.20 | -0.70 | -0.07 | -0.18 | -0.51 | -0.88 | -0.48 | -0.64 | -0.02 | 0.01 | 0.04 |
| EPS Diluted | -4.11 | 0.36 | 0.20 | -0.70 | -0.07 | -0.18 | -0.51 | -0.88 | -0.48 | -0.64 | -0.02 | 0.01 | 0.04 |
| Weighted Avg Shares Out | 15.67M | 15.11M | 14.54M | 12.68M | 12.09M | 11.72M | 11.01M | 10.04M | 9.73M | 7.08M | 10.98M | 10.98M | 10.98M |
| Weighted Avg Shares Out (Dil) | 15.67M | 15.11M | 14.54M | 12.68M | 12.09M | 11.72M | 11.01M | 10.04M | 9.73M | 7.08M | 10.98M | 10.98M | 10.98M |
7 Stocks With 1,000% Upside Potential
CareCloud, Inc. (CCLD) Q1 2023 Earnings Call Transcript
CareCloud to Present at the KeyBanc Life Sciences & MedTech Investor Forum
Source: https://incomestatements.info
Category: Stock Reports